Skip to main content
Sign In

Colorado School of Public Health

​​​​​​​​​
 

DPPOS

The Diabetes Prevention Program Outcomes Study


Dana Dabelea, MD, PhD, Principal Investigator.

The DPPOS is the long-term follow-up of the landmark Diabetes Prevention Program (DPP) trial that showed that lifestyle changes or the drug metformin effectively delay diabetes in overweight or obese American adults. Follow-up now exceeds fifteen years and the participants are being studied for further diabetes, heart disease, as well as aging related changes, and cancer.

Researchers involved: Dana Dabelea, Leigh Perreault

Results from the 10 year follow-up showed that lifestyle and metformin continued to delay or prevent diabetes:



​​

Colorado School of Public Health

13001 E. 17th Place
Mail Stop B119
Aurora, CO 80045


colorado.sph@ucdenver.edu

​​

© The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.